secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wave Life Sciences Ltd. (WVE)
CIK:        0001631574
Form:       8-K12B
Filed at:   2026-08-07T20:52:03+00:00
Accession:  0001193125-26-340430
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 3.03, 5.03, 5.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wave Life Sciences completes redomiciliation to Delaware; shares trade under WVE on Nasdaq
--------------------------------------------------------------------------------

- On Aug 7, 2026, Wave Life Sciences, Inc. (Delaware) became parent of Wave Life Sciences Ltd. (Singapore) via scheme of arrangement; shares exchanged 1:1.
- Wave-Delaware common stock begins trading on Nasdaq under symbol WVE on Aug 10, 2026; CUSIP 94352A104; Singapore shares delisted.
- Wave-Delaware assumed all equity plans and outstanding awards; pre-funded warrants now exercisable for Wave-Delaware common stock.
- Directors and officers of Wave-Singapore became directors and officers of Wave-Delaware; indemnification agreements entered into.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1631574/000119312526340430/0001193125-26-340430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1631574/000119312526340430/d122282d8k12b.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-340430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer